Since Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Intec Pharma Ltd. (NASDAQ:NTEC) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation of both companies.
In table 1 we can see Reata Pharmaceuticals Inc. and Intec Pharma Ltd.’s top-line revenue, earnings per share (EPS) and valuation.
Table 2 represents Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Intec Pharma Ltd. (NASDAQ:NTEC)’s return on equity, return on assets and net margins.
Insider Institutional Ownership
Reata Pharmaceuticals Inc. and Intec Pharma Ltd. has shares held by institutional investors as follows: 68.6% and 39.64%. Insiders held 4.1% of Reata Pharmaceuticals Inc. shares. Comparatively, 11.81% are Intec Pharma Ltd.’s share held by insiders.
In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance